指南与共识冠心病高血压

2017 ACC/AHA高血压指南对稳定性冠心病血压正常患者的潜在影响:CLARIFY注册研究启示

Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry.
指南 / 共识 · Eur Heart J · 2018-01-01

该研究基于CLARIFY注册中5956例无高血压或心衰史、平均血压<140/90 mmHg的稳定性冠心病患者,中位随访5.0年。多变量校正Cox模型显示,舒张压80-89 mmHg与主要终点(心血管死亡、心肌梗死或卒中)风险增加相关(HR 2.15,95%CI 1.22-3.81),而收缩压130-139 mmHg无显著关联。结果支持在冠心病患者中采用较低的舒张压而非收缩压高血压定义阈值和治疗目标。

要点

  • 稳定性冠心病患者舒张压80-89 mmHg与心血管事件风险增加独立相关。
  • 收缩压130-139 mmHg未显示与主要终点风险显著增加相关。
  • 结果支持较低舒张压而非收缩压的高血压定义阈值和治疗目标。

核心结论

  • 在按140/90 mmHg阈值定义为血压正常的稳定性冠心病患者中,舒张压80-89 mmHg与心血管风险增加相关,而收缩压130-139 mmHg无显著关联。

主要发现

  • 舒张压80-89 mmHg versus 70-79 mmHg的主要终点风险比为2.15(95%CI 1.22-3.81)。
  • 收缩压130-139 mmHg versus 120-129 mmHg的主要终点风险比为1.12(95%CI 0.64-1.97)。
  • 收缩压<120 mmHg或舒张压<70 mmHg未观察到主要终点风险显著增加。

临床怎么用

  • 在稳定性冠心病血压正常患者中,应关注舒张压80-89 mmHg的心血管风险,而非仅依据收缩压130-139 mmHg。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline on high blood pressure (BP) lowered the threshold defining hypertension and BP target in high-risk patients to 130/80 mmHg. Patients with coronary artery disease and systolic BP 130-139 mmHg or diastolic BP 80-89 mmHg should now receive medication to achieve this target. We aimed to investigate the relationship between BP and cardiovascular events in 'real-life' patients with coronary artery disease considered as having normal BP until the recent guideline. METHODS AND RESULTS: Data from 5956 patients with stable coronary artery disease, no history of hypertension or heart failure, and average BP <140/90 mmHg, enrolled in the CLARIFY registry (November 2009 to June 2010), were analysed. In a multivariable-adjusted Cox proportional hazards model, after a median follow-up of 5.0 years, diastolic BP 80-89 mmHg, but not systolic BP 130-139 mmHg, was associated with increased risk of the primary endpoint, a composite of cardiovascular death, myocardial infarction, or stroke (hazard ratio 2.15, 95% confidence interval 1.22-3.81 vs. 70-79 mmHg and 1.12, 0.64-1.97 vs. 120-129 mmHg). No significant increase in risk for the primary endpoint was observed for systolic BP <120 mmHg or diastolic BP <70 mmHg. CONCLUSION: In patients with stable coronary artery disease defined as having normal BP according to the 140/90 mmHg threshold, diastolic BP 80-89 mmHg was associated with increased cardiovascular risk, whereas systolic BP 130-139 mmHg was not, supporting the lower diastolic but not the lower systolic BP hypertension-defining threshold and treatment target in coronary artery disease. CLINICALTRIALS IDENTIFIER: ISRCTN43070564.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Vidal-Petiot E, Sorbets E, Bhatt DL, et al. Potential impact of the 2017 ACC/AHA guideline on high blood pressure in normotensive patients with stable coronary artery disease: insights from the CLARIFY registry. Eur Heart J. 2018. PMID: 30124796. doi:10.1093/eurheartj/ehy488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。